152 related articles for article (PubMed ID: 19369517)
1. Host Wnt/beta-catenin pathway triggered by Helicobacter pylori correlates with regression of gastric intestinal metaplasia after H. pylori eradication.
Hung KH; Wu JJ; Yang HB; Su LJ; Sheu BS
J Med Microbiol; 2009 May; 58(Pt 5):567-576. PubMed ID: 19369517
[TBL] [Abstract][Full Text] [Related]
2. Short-term celecoxib to regress long-term persistent gastric intestinal metaplasia after Helicobacter pylori eradication.
Hung KH; Yang HB; Cheng HC; Wu JJ; Sheu BS
J Gastroenterol Hepatol; 2010 Jan; 25(1):48-53. PubMed ID: 19793174
[TBL] [Abstract][Full Text] [Related]
3. Host single nucleotide polymorphisms of MMP-9 -1562/TIMP-1 372 have gender differences in the risk of gastric intestinal metaplasia after Helicobacter pylori infection.
Hung KH; Hung HW; Yang HB; Lu CC; Wu JJ; Sheu BS
Helicobacter; 2009 Dec; 14(6):580-7. PubMed ID: 19889076
[TBL] [Abstract][Full Text] [Related]
4. Changes in aberrant DNA methylation after Helicobacter pylori eradication: a long-term follow-up study.
Shin CM; Kim N; Lee HS; Park JH; Ahn S; Kang GH; Kim JM; Kim JS; Lee DH; Jung HC
Int J Cancer; 2013 Nov; 133(9):2034-42. PubMed ID: 23595635
[TBL] [Abstract][Full Text] [Related]
5. Aberrant DNA methylation in non-neoplastic gastric mucosa of H. Pylori infected patients and effect of eradication.
Perri F; Cotugno R; Piepoli A; Merla A; Quitadamo M; Gentile A; Pilotto A; Annese V; Andriulli A
Am J Gastroenterol; 2007 Jul; 102(7):1361-71. PubMed ID: 17509026
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of CDX2 in the gastric mucosa with and without intestinal metaplasia: effect of eradication of Helicobacter pylori.
Satoh K; Mutoh H; Eda A; Yanaka I; Osawa H; Honda S; Kawata H; Kihira K; Sugano K
Helicobacter; 2002 Jun; 7(3):192-8. PubMed ID: 12047325
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori eradication improves gastric atrophy and intestinal metaplasia in long-term observation.
Kodama M; Murakami K; Okimoto T; Abe T; Nakagawa Y; Mizukami K; Uchida M; Inoue K; Fujioka T
Digestion; 2012; 85(2):126-30. PubMed ID: 22269293
[TBL] [Abstract][Full Text] [Related]
8. Inability to noninvasively diagnose gastric intestinal metaplasia in Hispanics or reverse the lesion with Helicobacter pylori eradication.
Morales TG; Sampliner RE; Camargo E; Marquis S; Garewal HS; Fennerty MB
J Clin Gastroenterol; 2001; 32(5):400-4. PubMed ID: 11319310
[TBL] [Abstract][Full Text] [Related]
9. Relevance of high virulence Helicobacter pylori strains and futility of CDX2 expression for predicting intestinal metaplasia after eradication of infection.
Barros R; Peleteiro B; Almeida R; Figueiredo C; Barros H; David L; Lunet N
Scand J Gastroenterol; 2010 Aug; 45(7-8):828-34. PubMed ID: 20367284
[TBL] [Abstract][Full Text] [Related]
10. Analyzing the influence of gastric intestinal metaplasia on gastric ulcer healing in Helicobacter pylori-infected patients without atrophic gastritis.
Chen LW; Chang LC; Hua CC; Hsieh BJ; Chen SW; Chien RN
BMC Gastroenterol; 2017 Jan; 17(1):1. PubMed ID: 28049442
[TBL] [Abstract][Full Text] [Related]
11. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.
Liu D; He Q; Liu C
J Gastroenterol Hepatol; 2010 Apr; 25(4):795-9. PubMed ID: 20492336
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori promotes angiogenesis depending on Wnt/beta-catenin-mediated vascular endothelial growth factor via the cyclooxygenase-2 pathway in gastric cancer.
Liu N; Zhou N; Chai N; Liu X; Jiang H; Wu Q; Li Q
BMC Cancer; 2016 May; 16():321. PubMed ID: 27198692
[TBL] [Abstract][Full Text] [Related]
13. Long-term celecoxib can prevent the progression of persistent gastric intestinal metaplasia After H. pylori eradication.
Sheu BS; Tsai YC; Wu CT; Chang WL; Cheng HC; Yang HB
Helicobacter; 2013 Apr; 18(2):117-23. PubMed ID: 23067366
[TBL] [Abstract][Full Text] [Related]
14. Impact of Cyclooxygenase-2 1195 G-Carrier Genotype Associated with Intestinal Metaplasia and Endoscopic Findings Based on Kyoto Classification.
Kodaka Y; Futagami S; Tatsuguchi A; Yamawaki H; Sato H; Hashimoto S; Kawagoe T; Ueki N; Nagoya H; Maruki Y; Miyake K; Gudis K; Sakamoto C; Iwakiri K
Digestion; 2017; 96(3):173-183. PubMed ID: 28946145
[TBL] [Abstract][Full Text] [Related]
15. A follow-up study on the effect of Helicobacter pylori eradication on the severity of gastric histology.
Salih BA; Abasiyanik MF; Saribasak H; Huten O; Sander E
Dig Dis Sci; 2005 Aug; 50(8):1517-22. PubMed ID: 16110845
[TBL] [Abstract][Full Text] [Related]
16. Higher gastric cycloxygenase-2 expression and precancerous change in Helicobacter pylori-infected relatives of gastric cancer patients.
Sheu BS; Yang HB; Sheu SM; Huang AH; Wu JJ
Clin Cancer Res; 2003 Nov; 9(14):5245-51. PubMed ID: 14614005
[TBL] [Abstract][Full Text] [Related]
17. Mucosal barrier defects in gastric intestinal metaplasia: in vivo evaluation by confocal endomicroscopy.
Ji R; Zuo XL; Yu T; Gu XM; Li Z; Zhou CJ; Li YQ
Gastrointest Endosc; 2012 May; 75(5):980-7. PubMed ID: 22325805
[TBL] [Abstract][Full Text] [Related]
18. [Expression of pi glutathione S-transferase in intestinal metaplasia and its relationship with Helicobacter pylori infection].
Wang X; Wang L; Yuan Y
Zhonghua Yi Xue Za Zhi; 2002 Aug; 82(15):1033-6. PubMed ID: 12194793
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori eradication and antral intestinal metaplasia--two years follow-up study.
Ciok J; Dzieniszewski J; Lucer C
J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():115-22. PubMed ID: 9440062
[TBL] [Abstract][Full Text] [Related]
20. Gene expression patterns of COX-1, COX-2 and iNOS in H. Pylori infected histopathological conditions.
Tiwari SK; Shaik AS; Shaik AP; Alyousef AA; Bardia A; Habeeb MA; Khan AA
Microb Pathog; 2019 Oct; 135():103634. PubMed ID: 31325568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
